- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07378800
Fostering Positive Care Interactions in Assisted Living
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Rachel McPherson, PhD, MA
- Phone Number: 410-706-3689
- Email: rachelmcpherson@umaryland.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 55 years of age or older
- currently residing in a participating community
- Evidence of ADRD based on a score ≤20 on the Saint Louis University Mental Status Examination
Exclusion Criteria:
- Admitted to the assisted living for short term care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: FPCI-AL
The FPCI-AL is implemented using a research facilitator working with a community-based champion and stakeholder group to provide the following four-steps: (1) assessments of the environment and policy to facilitate positive interactions; (2) educating staff on fostering positive interactions; (3) establishing individualized positive care interaction approaches for residents and incorporating them into resident service plans; and (4) providing ongoing mentoring, motivating, and role modeling for staff to reinforce positive care interactions.
|
Following randomization, champions and stakeholder team members from the communities will be identified. The investigators will recommend the following individuals to be members of the stakeholder team: assisted living administrator, nurse manager, nursing assistant, and activity and rehabilitation staff as available. Following the initial team meeting, the research facilitator will work with each treatment assisted living community for eight hours weekly during months one and two, and then for four hours weekly for the remaining four months using a face-to-face approach to implement the four components of the FPCI-AL. |
|
Active Comparator: Education Only (EO)
Communities randomized to education only will receive the same education as provided in FPCI-AL step two via an established PowerPoint.
Delivery format will match community preferences (e.g., online or in-person) for pragmatic reasons and to facilitate the education process.
|
Communities randomized to education only will receive the same education as provided in FPCI-AL step two via an established PowerPoint.
Delivery format will match community preferences (e.g., online or in-person) for pragmatic reasons and to facilitate the education process.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Quality of Interactions Scale
Time Frame: Baseline, 4 months, 6 months
|
Quality of care interactions will be measured using the Modified Quality of Interactions Scale, an observational tool that measures interaction characteristics and quality using a quantified scoring system.
It records the care interaction location, type of care activity, and type of care provider in care (e.g., nurse).
The total score ranges from 0 to 7, with higher scores indicating better, more positive interactions.
|
Baseline, 4 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neuropsychiatric Inventory Questionnaire
Time Frame: Baseline, 4 months, 6 months
|
The Neuropsychiatric Inventory Questionnaire (NPI-Q) assesses the presence, severity, and impact on caregivers of 12 behavioral symptoms of distress (e.g., delusions, hallucinations, anxiety).
For the purposes of this study only the presence of behavior will be considered.
The total score ranges from 0 to 12, with higher numbers indicating more behavioral symptoms of distress.
|
Baseline, 4 months, 6 months
|
|
Resistiveness to Care Scale
Time Frame: Baseline, 4 months, 6 months
|
Resistiveness to care will be assessed during care interactions using the Resistiveness to Care Scale, which measures the frequency of 16 resistive behaviors (e.g., kicking, hitting).
The total score ranges from 0 to 16, with higher scores indicating more resistiveness to care behaviors.
|
Baseline, 4 months, 6 months
|
|
Resident Engagement with Staff During Care Interactions
Time Frame: Baseline, 4 months, 6 months
|
The Modified Quality of Interaction Scale item, "What is the level of resident engagement?", will be used during assessments of staff-resident care interactions to record resident engagement as active, passive, or restrictive.
|
Baseline, 4 months, 6 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AARG-25-1481519
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
NYU Langone HealthRecruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
Clinical Trials on FPCI-AL
-
Alcon ResearchWithdrawn
-
Alios Biopharma Inc.Completed
-
Hospital General Universitario ElcheUnknown
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
University of California, San FranciscoCompletedProgressive Supranuclear Palsy | Corticobasal Degeneration Syndrome | Progressive Nonfluent Aphasia | Predicted Tauopathies, Including | Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17United States
-
Riphah International UniversityCompletedStuttering, AdultPakistan
-
Common SenseCompletedAmniotic ProblemsUnited States
-
Cairo UniversityNot yet recruiting